Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more
Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more
Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.
Mozobil is a… read more
Overview
Tecvayli is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These… read more
Overview
Talvey is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These…
Overview
Carvykti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy.… read more
Overview
Elrexfio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who’ve received at least four prior lines of therapy,… read more